Canada In Vitro Fertilization (IVF) Service Market Analysis Report 2023 to 2030

Canada In Vitro Fertilization (IVF) Service Market Analysis

$ 3999

In Vitro Fertilization (IVF) is a complex assisted reproductive technology (ART) designed to facilitate conception by fertilizing an egg outside the body. The procedure starts with ovarian stimulation to produce multiple eggs, which are then collected and mixed with sperm in a lab. Once fertilization occurs, the resulting embryo is transferred into the woman's uterus in hopes of achieving pregnancy. IVF is typically pursued when other fertility treatments have failed or when specific fertility issues, such as blocked fallopian tubes, endometriosis, or low sperm count, are present.

ID: IN10CAHS011 CATEGORY: Healthcare Services GEOGRAPHY: Canada AUTHOR: Aashwi Mehta

Buy Now

Canada In Vitro Fertilization (IVF) Service Market Executive Summary

The Canada In Vitro Fertilization (IVF) Service Market was valued at $1796 Mn in 2023 and is predicted to grow at a CAGR of 7.42% from 2023 to 2030, to $2964.16 Mn by 2030.

According to the Canadian Fertility and Andrology Society (CFAS), approximately one in six Canadians experience infertility. Across Canada, about 35 fertility clinics perform around 20,000 cycles of fertility treatment annually. In 2022, Canada's total fertility rate (TFR) hit a record low of 1.33 children per woman. The market is driven by significant factors like the high prevalence of infertility, delayed parenthood, and declining fertility rates. However, high costs, ethical concerns, and complications and risks restrict the growth and potential of the market.

Prominent players in this field include CooperSurgical, Generation Fertility, IVF Canada, and TRIO Fertility among others.

Canada In Vitro Fertilization (IVF) Service Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

High Prevalence of Infertility: With around 1 in 6 Canadians experiencing infertility, the demand for assisted reproductive technologies like IVF is significant. This high prevalence of infertility drives the need for advanced reproductive treatments and services in the country.

Delayed Parenthood: Shifts in cultural norms towards later parenthood are impacting the IVF market. This trend increases the demand for IVF services as more individuals and couples seek fertility treatments to conceive at older ages, driving market growth in Canada.

Declining Fertility Rates: In 2022, Canada’s total fertility rate hit a record low of 1.33 children per woman, underscoring the increasing need for fertility treatments. This decline in fertility rates boosts the demand for IVF services as more individuals and couples seek assistance to achieve parenthood.

Market Restraints

High Costs: The substantial expense of IVF treatments often puts them out of reach for many Canadians, limiting accessibility and restraining market expansion. This financial barrier prevents a larger portion of the population from seeking IVF services, thereby impacting the overall market growth.

Ethical Concerns: Ethical debates concerning embryo selection, genetic testing, and surrogacy can result in stringent regulations and legal restrictions, potentially complicating access to IVF services and hindering market expansion in Canada.

Complications and Risks: IVF treatments do not ensure a successful pregnancy and come with risks such as infections, bleeding, and complications. The potential for multiple births, which can result in low birth weight and premature delivery, also poses concerns, deterring some individuals from pursuing IVF services in Canada.

Regulatory Landscape and Reimbursement Scenario

The Ministry of Health in Canada directs healthcare services and policy, allocates funds, and maintains national health standards. Health Canada ensures the safety and effectiveness of health products, including food and pharmaceuticals. Health Canada oversees policy and regulations under the Assisted Human Reproduction Act (AHR Act), which outlines prohibited activities in assisted reproduction that could pose health risks or are considered ethically unacceptable. In Canada, coverage for in vitro fertilization (IVF) services differs by province; some offer partial or full funding, while others provide tax credits for fertility-related expenses. Beginning April 1, 2025, the British Columbia government will provide coverage for one cycle of IVF.

Competitive Landscape

Key Players

Here are some of the major key players in the Canada In Vitro Fertilization (IVF) Service Market:

CooperSurgical
Generation Fertility
IVF Canada
TRIO Fertility
Newlife Fertility Centre
PCRM
CCRM Fertility
ELITE IVF
ReproMed Fertility
Reproductive Care Centre

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada In Vitro Fertilization (IVF) Service Market Segmentation

By Cycle Type

Fresh IVF Cycles
Thawed IVF Cycles
Donor Egg/Sperm IVF Cycles

By End Users

Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.